Clinical Trial: Scientific title A randomized controlled study to evaluate the safety and efficacy of Yukeshu medical recombinant collagen gel in patients with pathological scars after surgery combined with radiotherapy (China)

China, Sept. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Scientific title A randomized controlled study to evaluate the safety and efficacy of Yukeshu medical recombinant collagen gel in patients with pathological scars after surgery combined with radiotherapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131459

Registration Time: 2026/09/02

Type: Interventional study

Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336724

Published by HT Digital Content Services with permission from Health Daily Digest....